Navamedic ASA: Invitation to presentation of fourt

Navamedic ASA will present its fourth quarter 2016 report in an extended eventon Wednesday, February 15 2017 at Hotel Continental in Oslo, Norway. Navamedicis proud to announce Prof. Jan Van Der Linden from Karolinska Institutet askeynote speaker for the session focusing on the Sippi® technology platform andmarket opportunities.Agenda (times in CET): 08:00-08:20: Q4 2016 presentation by Tom Rönnlund, CEO of Navamedic ASA 08:25-08:30: Break 08:30-08:55: Current research Sippi Jan Van Der Linden, Professor and Senior Physician at Karolinska Institutet, Department of Molecular Medicine and Surgery and Research group, leader of the group Cardiothoracic Anesthesiology and Intensive Care.  08:55-09:15: Magnus Emmoth, CEO of Navamedic Medtech ABA light breakfast will be served from 07:30.The presentation will be live streamed at www.navamedic.com-investor relations-presentations-webcast at 08.00 CET. Shortly after the presentation the webcast recording will be published on the same site.For further information, please contact:Toril Ås, CFO of NavamedicPhone: +47 67 11 25 40Email: toril.as@navamedic.comNavamedic ASA is a Norwegian medtech and pharmaceutical products company,delivering products to patients, hospitals and pharmacies in the Nordic andEuropean markets. The Group's Medtech business has developed and is currentlyintroducing the next generation of digital urine meter Sippi®. Navamedic'sPharma and Healthcare business is a distributor of products supplied by a numberof pharmaceutical manufacturers. Navamedic is listed on the Oslo Stock Exchange(ticker: NAVA).